These findings further confirmed that piR-63049 was negatively correlated with osteoporosis while inhibiting piR-63049 in vivo can rescue bone loss in OVX rats by promoting bone formation, which may be a useful therapeutic strategy for postmenopausal osteoporosis. The gene discussed is PIR; the disease is osteoporosis.